ABPO
Abpro Holdings, Inc.C6215-min delayed · EOD close0.22 +0.00% upas of 2026-09-02mkt cap $1.3M
Biological Products, (No Diagnostic Substances) · SIC 2836 · CIK 0001893219
Quality score
62/100
C
Growth100
Business quality50
missing: grossMargin, roe
Financial health12
missing: debtToEquity
Valuation84
missing: pbRatio
Computed from filed fundamentals against fixed reference bands. Not a recommendation, and not a peer percentile.
The read
Mixed picture
Highly uneven
Strongest on growth (100), weakest on financial health (12). The composite is the mean of the sub-scores that could be computed. 4 inputs were unavailable in the filings, so the score reflects what was reported.
Revenue growth
50.0%
year over year
Earnings growth
218.1%